Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Filter Results

1337 News Releases Found

Sara M. Tolaney, MD, MPH
News Releases
2/3/2023

Dana-Farber research supports FDA approval of new therapy for metastatic breast cancer

  • Breast Cancer
_
News Releases
2/1/2023

Season two of Unraveled podcast now available

_
News Releases
2/1/2023

Four elected to Dana-Farber Board of Trustees

Ursula A. Matulonis, MD
News Releases
1/30/2023

Results of the SORAYA study show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

  • Ovarian Cancer
News Releases
1/25/2023

Study Links Key Activating Enzymes to Specific Sites on Proteins in Cells

  • Research
More than 120 Dana-Farber affiliated faculty named as 2023 Top Doctors in Boston Magazine
News Releases
1/24/2023

More than 120 Dana-Farber affiliated faculty named as 2023 Top Doctors in Boston Magazine

An image of colon cancer, with cancer cells forming circled structures. Photographed by Shuji Ogino, MD, PhD.
News Releases
1/21/2023

Immunotherapy with two novel drugs shows activity in colorectal cancer

  • Research
  • Immunotherapy
  • Rectal Cancer
  • Colon Cancer
Jennifer R. Brown, MD, PhD
News Releases
1/20/2023

Dana-Farber Led Study Leads to FDA Approval for Next-Generation Drug in Relapsed Chronic Lymphocytic Leukemia

  • Chronic Lymphocytic - CLL
Rachel Pozzar, PhD, RN, has been awarded the 2023 Oncology Nursing Society’s (ONS) Victoria Mock New Investigator Award.
News Releases
1/17/2023

Dana-Farber researcher awarded Victoria Mock New Investigator Award

  • Research